Evidence map›Paper›PMID 28242709›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.

Luz E Tavera-Mendoza, Thomas Westerling, Eric Libby, Andriy Marusyk, Laura Cato, Raymundo Cassani, Lisa A Cameron, Scott B Ficarro, Jarrod A Marto, Jelena Klawitter and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. 1,25D3 reprograms mitochondrial quality control via sirtuin and sensitizes glioblastoma to chemotherapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Luz E Tavera-MendozaDivision of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
Thomas WesterlingDivision of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
Eric LibbySanta Fe Institute, Santa Fe, NM 87501.
Andriy MarusykDepartment of Cancer Imaging and Metabolism, Moffitt Cancer Center, University of South Florida, Tampa, FL 33612.
Laura CatoDivision of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
Raymundo CassaniInstitut National de la Recherche Scientifique, Centre Énergie, Matériaux, Télécommunications, University of Quebec, Montreal, QC H5A 1K6, Canada.
Lisa A CameronConfocal and Light Microscopy Core, Dana-Farber Cancer Institute, Boston, MA 02215.
Scott B FicarroBlais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02215.
Jarrod A MartoBlais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02215.
Jelena KlawitterDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Myles BrownDivision of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215; myles_brown@dfci.harvard.edu.
Dana-Farber Cancer Institute · USHarvard University · USInstitut National de la Recherche Scientifique · CASanta Fe Institute · USUniversity of Colorado Anschutz Medical Campus · USUniversity of South Florida · US

Funding

Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of ClonalP01CA080111 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI DILLON, DEBORAH · 1999 to 2018
$36.0M
NCI NIH HHS P01 CA080111
6 · The paper itself

Abstract

Women in North America have a one in eight lifetime risk of developing breast cancer (BC), and a significant proportion of these individuals will develop recurrent BC and will eventually succumb to the disease. Metastatic, therapy-resistant BC cells are refractory to cell death induced by multiple stresses. Here, we document that the vitamin D receptor (VDR) acts as a master transcriptional regulator of autophagy. Activation of the VDR by vitamin D induces autophagy and an autophagic transcriptional signature in BC cells that correlates with increased survival in patients; strikingly, this signature is present in the normal mammary gland and is progressively lost in patients with metastatic BC. A number of epidemiological studies have shown that sufficient vitamin D serum levels might be protective against BC. We observed that dietary vitamin D supplementation in mice increases basal levels of autophagy in the normal mammary gland, highlighting the potential of vitamin D as a cancer-preventive agent. These findings point to a role of vitamin D and the VDR in modulating autophagy and cell death in both the normal mammary gland and BC cells.

Indexed as

AutophagyAmino Acid MotifsAnimalsBinding SitesBiomarkersBreastBreast NeoplasmsCell Line, TumorDisease Models, AnimalDisease ProgressionFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHeterograftsHumansBiomarkersReceptors, CalcitriolVitamin Dautophagybreast canceroncologyvitamin Dvitamin D signaling

Identifiers

PMID28242709
PMCPMC5358377
OpenAlexW2592922319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.